What is the price of zomedica stock now?
Mar 31, 2022 · Zomedica's stock was trading at $0.2078 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, ZOM shares have increased by 51.1% and is now trading at $0.3140.
Is zomedica too risky at $2?
Jun 04, 2021 · Zomedica stock has been on an uptrend. How high can ZOM stock go in short squeeze 2.0? Will the stock move above $1?
Will zomedica stock outperform or underperform the S&P 500 over the long term?
Apr 22, 2020 · Wednesday, April 22, 2020 01:17 PM | InvestorsObserver Analysts. Analysts who follow Zomedica Pharmaceuticals Corp ( ZOM) on average expect it to gain 333.33% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy.
What price target do analysts set for zomedica?
4) Revenue for 2021 was 4.1M .vs. 0 and with margins of 74% 5) Stock did go up due to Meme activities which has nothing to do with fundamental. Stock was .08 …
Is Zomedica Pharmaceuticals a good stock to buy?
In the final analysis, ZOM stock is highly risky and best suited for speculative traders. Yet it's possible that retail traders will bid the stock up in 2022. And if they abandon Zomedica, it would be a dog-gone shame.Jan 7, 2022
What is the prediction for Zomedica stock?
Zomedica (ZOM) Monthly Stock Prediction for 2025MonthTargetOpt.Mar0.300.34Apr0.310.33May0.290.32Jun0.340.376 more rows
Will Zomedica go up tomorrow?
Tomorrow's movement Prediction of Zomedica Pharmaceuticals Corp ZOM as on 08 Apr 2022 appears strongly Bullish. This stock started moving upwards as soon as it opened....Munafa value: 55 as on 08 Fri Apr 2022.Upside target0.33Upside target0.31Downside target0.3Downside target0.291 more row
Will Zomedica stock go up in 2022?
Target values for the price of one Zomedica share for May 2022. The weighted average target price per Zomedica share in May 2022 is: 0.36. In May, the positive dynamics for Momo shares will prevail with possible monthly volatility of 11.441% volatility is expected.
Will Zomedica stock recover?
There is potential for a short term uptick in the Zom stock price, especially as the active weekly candle is mildly bullish. The relative strength index is relatively oversold and has been for quite some time. A mild divergence also supports the notion of a slight recovery in the Zom stock price in the near term.Feb 4, 2022
How high does IDEX go?
IDEX stock hit a 2022 high of $1.44 in early January and a low of $0.87 later in the same month. In 2021 its stock price ranged from 88 cents to $5.53. In an interview with Capital.com, Vinod Jain, senior analyst at Aite-Novarica Group, said “the stock could see more volatility due to its current price point”.Mar 22, 2022
Why is ZOM dropping?
CEO Robert Cohen said the move was precipitated by "changes at our current distributor that we believe have impacted its ability to market our products effectively." Those words likely startled investors, many of whom decided to sell their shares. Zomedica's stock price dropped sharply on Thursday.Apr 15, 2021
How has Zomedica's stock been impacted by COVID-19 (Coronavirus)?
Zomedica's stock was trading at $0.2078 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organ...
When is Zomedica's next earnings date?
Zomedica is scheduled to release its next quarterly earnings announcement on Tuesday, May 10th 2022. View our earnings forecast for Zomedica .
How were Zomedica's earnings last quarter?
Zomedica Corp. (NYSEAMERICAN:ZOM) issued its quarterly earnings results on Thursday, November, 12th. The company reported ($0.01) earnings per shar...
What guidance has Zomedica issued on next quarter's earnings?
Zomedica issued an update on its FY 2021 earnings guidance on Monday, March, 14th. The company provided earnings per share (EPS) guidance of for th...
Who are Zomedica's key executives?
Zomedica's management team includes the following people: Mr. Robert Cohen , CEO & Director (Age 63, Pay $412.79k) Ms. Ann Marie Cotter CPA , C...
Who are some of Zomedica's key competitors?
Some companies that are related to Zomedica include Protagonist Therapeutics (PTGX) , Keros Therapeutics (KROS) , Myovant Sciences (MYOV) , Axs...
What is Zomedica's stock symbol?
Zomedica trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ZOM."
Who are Zomedica's major shareholders?
Zomedica's stock is owned by a variety of retail and institutional investors. Top institutional investors include State Street Corp (2.93%), BlackR...
Which institutional investors are selling Zomedica stock?
ZOM stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Geode Capital Management LLC, Commonwealt...
Is a short squeeze happening in ZOM stock?
ZOM stock has gained 22.9 percent over the last 10 days. This has left many investors wondering whether a short squeeze 2.0 is happening in the stock. According to data from Fintel, over 50 million shares of ZOM stock were sold short on June 3, which was 35 percent of the trading volume on that day.
Be patient with ZOM stock
Zomedica went overboard with stock issuance and as a result, it had cash and cash equivalents of $276.6 million as of March 31, 2021. The stock issuance was done at a higher price than what ZOM currently trades at.
Zomedica stock price prediction
Only H.C. Wainwright has provided a forecast for ZOM stock and analyst Swayampakula Ramakanth has a buy rating with a $1.2 target price on the stock. Interestingly, H.C. Wainwright participated in the bought-out stock offering for Zomedica in the first quarter of 2021. The shares were sold at $1.90, which is almost twice the current stock price.
Signals & Forecast
The Zomedica Pharmaceuticals Corp stock holds a sell signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock.
Support, Risk & Stop-loss
Zomedica Pharmaceuticals Corp finds support from accumulated volume at $0.58 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
Is Zomedica Pharmaceuticals Corp stock A Buy?
Zomedica Pharmaceuticals Corp holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Why are Analyst Ratings Important?
A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe.
What's Happening With Zomedica Pharmaceuticals Corp Stock Today?
Zomedica Pharmaceuticals Corp (ZOM) stock is down -4.16% while the S&P 500 has risen 1.98% as of 1:13 PM on Wednesday, Apr 22. ZOM is down -$0.01 from the previous closing price of $0.15 on volume of 6,907,980 shares. Over the past year the S&P 500 is down -4.87% while ZOM is down -59.46%. ZOM lost -$0.19 per share the over the last 12 months.
